Corcept Therapeutics (CORT) Tops Q1 EPS by 1c
Get Alerts CORT Hot Sheet
Price: $24.31 +4.65%
EPS Growth %: +64.3%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
BFRI, HCTI, IMPM, More
EPS Growth %: +64.3%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
BFRI, HCTI, IMPM, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $16.1 million versus the consensus estimate of $16.32 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FreightCar America (RAIL) Misses Q4 EPS by 6c, provides guidance
- Tango Therapeutics, Inc. (TNGX) Misses Q4 EPS by 5c
- RF Industries (RFIL) Misses Q1 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!